Neurologic Autoimmunity in the Era of Checkpoint Inhibitor Cancer Immunotherapy

Mayo Clinic Proceedings - Netherlands
doi 10.1016/j.mayocp.2019.02.003
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Elsevier BV

Related search

Nonmuscle Invasive Urothelial Cancer— Bacillus Calmette–Guérin Instillation or Checkpoint Inhibitor Immunotherapy?

Memo - Magazine of European Medical Oncology
OncologyHematology
2019English

Tumor Immunity and Autoimmunity Following Cancer Immunotherapy

English

Unleashing the Tiger – Iatrogenic Autoimmunity From Cancer Immunotherapy Drugs

JRSM Open
2018English

Combination Strategies of Checkpoint Immunotherapy in Metastatic Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2020English

Autoantibodies Against Neurologic Antigens in Nonneurologic Autoimmunity

Journal of Immunology
AllergyImmunology
2019English

Systemic Immunotherapy of Superficial Mouse Bladder Cancer With Avelumab (MSB0010718C), an Anti-Pd-L1 Immune Checkpoint Inhibitor

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Loss of Fas Expression and Function Is Coupled With Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2018English

Autoimmunity and Immunotherapy in Narcolepsy

Sleep Medicine Research
Mental HealthNeurologyPsychiatryPulmonaryRespiratory MedicinePhysiology
2017English

Back to the Future: Rethinking and Retooling IL2 in the Immune Checkpoint Inhibitor Era

Cancer Discovery
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy